NuProbe is a genomics company based in Cambridge, MA that specializes in developing high-sensitivity research assays for the detection and monitoring of low-frequency mutations in oncology research. Their innovative products enable laboratories to detect and quantify low-abundant variants in both cell-free DNA and tissue specimens, accelerating precision oncology worldwide.
With a focus on biomarker detection, NuProbe also provides assay development and testing services to support all stages of biomarker detection programs for pharmaceutical companies. Their flexible platform utilizes proprietary technologies to deliver best-in-class sensitivity for solid tumor and liquid biopsy samples, offering customized solutions to meet the specific needs of their clients.
Generated from the website